東北大学加齢医学研究所 臨床腫瘍学分野 東北大学 腫瘍内科

研究関係

HOME < 研究業績 < 英文論文 2015年度

英文論文 2015年度

  1. Kobayashi, A.,Takahashi, M.,Imai, H.,Akiyama, S.,Sugiyama, S.,Komine, K.,Saijo, K.,Takahashi, M.,Takahashi, S.,Shirota, H.,Sato, N.,Fujishima, F.,Shuin, T.,Shimodaira, H.,Ishioka, C.: Attainment of a Long-term Favorable Outcome by Sunitinib Treatment for Pancreatic Neuroendocrine Tumor and Renal Cell Carcinoma Associated with von Hippel-Lindau Disease. Intern Med 55. 629-34. Mar 18(2016)
  2. Ouchi, K.,Takahashi, S.,Yamada, Y.,Tsuji, S.,Tatsuno, K.,Takahashi, H.,Takahashi, N.,Takahashi, M.,Shimodaira, H.,Aburatani, H.,Ishioka, C.: DNA methylation status as a biomarker of anti-EGFR treatment for metastatic colorectal cancer. Cancer Sci 106. 1722–1729. Oct 1(2015)
  3. Komatsu, Y.,Ishioka, C.,Shimada, K.,Yamada, Y.,Gamoh, M.,Sato, A.,Yamaguchi, T.,Yuki, S.,Morita, S.,Takahashi, S.,Goto, R.,Kurihara, M.: Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer. BMC Cancer 15. 626. Sep 12(2015)
  4. Yoshino, Y.,Ishioka, C.: Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Scientific Reports 5. 13249. Aug 21(2015)
  5. Yoshino, Y.,Suzuki, M.,Takahashi, H.,Ishioka, C.: Inhibition of invasion by glycogen synthase kinase-3 beta inhibitors through dysregulation of actin re-organisation via down-regulation of WAVE2. Biochem Biophys Res Commun 464. 275-80. Aug 14(2015)
  6. Watanabe, G.,Ishida, T.,Furuta, A.,Takahashi, S.,Watanabe, M.,Nakata, H.,Kato, S.,Ishioka, C.,Ohuchi, N.: Combined Immunohistochemistry of PLK1, p21, and p53 for Predicting TP53 Status: An Independent Prognostic Factor of Breast Cancer. Am J Surg Pathol 39. 1026-34. Aug(2015)
  7. Mori, T.,Sumii, M.,Fujishima, F.,Ueno, K.,Emi, M.,Nagasaki, M.,Ishioka, C.,Chiba, N.: Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma. Cancer Sci 106. 1118-1129. Jun 17(2015)
  8. Inoue, M.,Takahashi, S.,Soeda, H.,Shimodaira, H.,Watanabe, M.,Miura, K.,Sasaki, I.,Kato, S.,Ishioka, C.: Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer. Int J Clin Oncol 20. 1147-1155. May 20(2015)
  9. Shirota, H.,Tross, D.,Klinman, D.: CpG Oligonucleotides as Cancer Vaccine Adjuvants. Vaccines 3. 390-407. May 8(2015)
  10. Hiratsuka, M.,Yamashita, H.,Akai, F.,Hosono, H.,Hishinuma, E.,Hirasawa, N.,Mori, T.: Genetic polymorphisms of dihydropyrimidinase in a Japanese patient with capecitabine-induced toxicity. PLoS One 10. e0124818. Apr 29(2015)
  11. Ohkawa, S.,Okusaka, T.,Isayama, H.,Fukutomi, A.,Yamaguchi, K.,Ikeda, M.,Funakoshi, A.,Nagase, M.,Hamamoto, Y.,Nakamori, S.,Tsuchiya, Y.,Baba, H.,Ishii, H.,Omuro, Y.,Sho, M.,Matsumoto, S.,Yamada, N.,Yanagimoto, H.,Unno, M.,Ichikawa, Y.,Takahashi, S.,Watanabe, G.,Wakabayashi, G.,Egawa, N.,Tsuda, M.,Hosotani, R.,Hamada, C.,Hyodo, I.: Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer. Br J Cancer 112. 1428-34. Apr 28(2015)

ページの先頭へ戻る

© 2006 Department of Medical Oncology, Tohoku University Hospital All rights reserved.